SCHEMBL2486782

SCHEMBL2486782

O=C(Nc1ccc(OC(F)(F)F)c(Cl)c1)Oc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.70
PNLIP P16233 2/20 0.55
ALDH1A1 P00352 6/20 0.50
MAPT P10636 5/20 0.50
KDM4E B2RXH2 2/20 0.50
S1PR2 O95136 3/20 0.49
CYP1A2 P05177 1/20 0.48
RAD51 Q06609 1/20 0.48
EPHX2 P34913 1/20 0.47
MALT1 Q9UDY8 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
THRB P10828 1/20 0.46
GFER P55789 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HTR1E P28566 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16907580 0.90 POLB (0.60) POLBPNLIPALDH1A1MAPTKDM4E
SCHEMBL12073166 0.85 POLB (0.56) POLBALDH1A1MAPTKDM4ECYP1A2
SCHEMBL23213594 0.84 POLB (0.56) POLBPNLIPALDH1A1MAPTKDM4E
SCHEMBL29716363 0.84 POLB (0.56) POLBPNLIPALDH1A1MAPTKDM4E
SCHEMBL14945015 0.84 POLB (0.65) POLBALDH1A1MAPTKDM4ECYP1A2
SCHEMBL3632333 0.83 MEN1 (0.54) POLBPNLIPALDH1A1MAPTEPHX2
SCHEMBL16907579 0.83 FAAH (0.53) POLBALDH1A1MAPTKDM4ECYP1A2
SCHEMBL29739392 0.83 FAAH (0.53) POLBALDH1A1MAPTKDM4ECYP1A2
SCHEMBL31028641 0.83 POLB (1.00) POLBALDH1A1MAPTCYP1A2MEN1
SCHEMBL23213624 0.82 POLB (0.53) POLBALDH1A1MAPTKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921373-B2 Compounds having TRPV1 antagonistic activity and uses thereof SHIONOGI & CO., LTD. (JP) 2014-12-30 US disclosed
US-8921373-B2 Compounds having TRPV1 antagonistic activity and uses thereof SHIONOGI & CO., LTD. (JP) 2014-12-30 US disclosed
EP-2727913-A1 (4-Tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives Astrazeneca AB (SE) 2014-05-07 EP disclosed
US-20130289043-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES ASTRAZENECA AB (SE) 2013-10-31 US disclosed
US-20130123239-A1 COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF PURDUE PHARMA L.P. 2013-05-16 US disclosed
US-20130123239-A1 COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF PURDUE PHARMA L.P. 2013-05-16 US disclosed
US-20120289513-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES ASTRAZENECA AB (SE) 2012-11-15 US disclosed
CN-102317273-A (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES ASTRAZENECA AB 2012-01-11 CN disclosed
WO-2011162409-A1 COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF SHIONOGI & CO., LTD. (JP) 2011-12-29 WO disclosed
EP-2379519-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES AstraZeneca AB (SE) 2011-10-26 EP disclosed
WO-2010071567-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES ASTRAZENECA AB (SE) 2010-06-24 WO disclosed
US-20100152197-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES ASTRAZENECA AB (SE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289043-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES CCR2, CCR5, CNR2 POLB 779/4885PNLIP 3133/4885ALDH1A1 1115/4885
US-20130123239-A1 COMPOUNDS HAVING TRPV1 ANTAGONISTIC ACTIVITY AND USES THEREOF TRPV1, TRPA1, TRPV2 POLB 4864/4885PNLIP 2822/4885ALDH1A1 1526/4885
US-20100152197-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES CCR2, CCR5, CNR2 POLB 779/4885PNLIP 3133/4885ALDH1A1 1115/4885
US-20120289513-A1 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES CCR2, CCR5, CNR2 POLB 779/4885PNLIP 3133/4885ALDH1A1 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.